Virginie Lobrégat-Duriez

Virginie Lobrégat-Duriez has extensive work experience in the pharmaceutical industry. Virginie is currently the Director of Clinical Operations at Immutep Limited, a position they have held since March 2021. Prior to this, they served as a Board Member at Association des Métiers Médicaux des Industries de Santé (AMMIS) starting from March 2020.

From 2014 to November 2020, Virginie worked at Actelion as the Head of Clinical Operations for France, Belgium, and the Netherlands. Before that, they held the position of Clinical Operations Coordinator for the same regions from 2009 to 2014.

Virginie began their career at ICON Clinical Research in 2001. Virginie held various roles, including Clinical Research Associate, Study start-up specialist, and CRA Manager. As a CRA Manager, they were responsible for managing a team of 20 CRAs, overseeing recruitment and talent development, setting goals, managing workload, ensuring monitoring quality, training on new procedures, and creating a handbook for new employees.

Overall, Virginie Lobrégat-Duriez has a diverse and accomplished background in clinical operations and research within the pharmaceutical industry.

Virginie Lobrégat-Duriez has a diverse education background in the field of chemistry and health industries. In 1991, they obtained an engineering degree from the Institut national des Sciences appliquées de Rouen, specializing in chemistry. Virginie continued their academic journey by pursuing a post-graduate degree (DEA) in chemistry at the Université de Rouen from 1996 to 1997. Following this, they completed their PhD in Chemistry from Université de Rennes I between 1997 and 2000, specializing in organic chemistry. Recently, in 2019, Virginie Lobrégat-Duriez attended ESSEC Business School, where they obtained an Executive Master in "Strategy and Management of Health Industries," focusing on health industries and innovation.